A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients

MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients

(2020) Valentina Pegoraro et al.   CLINICAL NEUROPATHOLOGY

Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis

(2020) Marco Ceccanti et al.   Cells

Metabolic Changes Associated With Muscle Expression of SOD1G93A

(2018) Gabriella Dobrowolny et al.   Frontiers in Physiology

MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis

(2018) Claudia Ricci et al.   Cells

Predicting functional decline and survival in amyotrophic lateral sclerosis

(2017) Mei-Lyn Ong et al.   PLoS One

Amyotrophic lateral sclerosis or not: Keys for the diagnosis

(2017) T. Lenglet et al.   REVUE NEUROLOGIQUE

Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS

(2016) Elisabetta Tasca et al.   CLINICAL NEUROPATHOLOGY

Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis

(2016) M. K. Rafiq et al.   EUROPEAN JOURNAL OF NEUROLOGY

MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis

(2016) Helen M.T. de Andrade et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Postmitotic Expression of SOD1G93AGene Affects the Identity of Myogenic Cells and Inhibits Myoblasts Differentiation

(2015) Martina Martini et al.   MEDIATORS OF INFLAMMATION

Muscle Expression of SOD1G93A Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice

(2015) Gabriella Dobrowolny et al.   Frontiers in Cellular Neuroscience

Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis

(2015) Ikuko Takahashi et al.   Molecular Brain

Quantifying disease progression in amyotrophic lateral sclerosis

(2014) Neil G. Simon et al.   ANNALS OF NEUROLOGY

Trimmomatic: a flexible trimmer for Illumina sequence data

(2014) Anthony M. Bolger et al.   BIOINFORMATICS

miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients

(2014) Bruna De Felice et al.   NEUROGENETICS

MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis

(2014) Janne M. Toivonen et al.   PLoS One

MicroRNAs in cancer: biomarkers, functions and therapy

(2014) Josie Hayes et al.   TRENDS IN MOLECULAR MEDICINE

Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine

(2014) Adriano Chiò et al.   JAMA Neurology

Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression

(2013) Gaëlle Bruneteau et al.   BRAIN

Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis

(2013) Philip Van Damme et al.   CURRENT OPINION IN NEUROLOGY

Understanding ALS: new therapeutic approaches

(2012) Antonio Musarò   FEBS Journal

miRNAs as serum biomarkers for Duchenne muscular dystrophy

(2011) Davide Cacchiarelli et al.   EMBO Molecular Medicine

Hypermetabolism in ALS patients: an early and persistent phenomenon

(2009) C. Bouteloup et al.   JOURNAL OF NEUROLOGY

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

(2009) Ben Langmead et al.   GENOME BIOLOGY

Electrodiagnostic criteria for diagnosis of ALS

(2008) Mamede de Carvalho et al.   CLINICAL NEUROPHYSIOLOGY

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

(2008) L. Dupuis et al.   NEUROLOGY